- Home
- YSXT vs MCRB Comparison
YSXT vs MCRB Comparison
Compare YSXT & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- YSXT
- MCRB
- Stock Information
- Founded
- YSXT 2011
- MCRB 2010
- Country
- YSXT China
- MCRB United States
- Employees
- YSXT N/A
- MCRB N/A
- Industry
- YSXT Automotive Aftermarket
- MCRB Biotechnology: Pharmaceutical Preparations
- Sector
- YSXT Consumer Discretionary
- MCRB Health Care
- Exchange
- YSXT Nasdaq
- MCRB Nasdaq
- Market Cap
- YSXT 125.2M
- MCRB 125.7M
- IPO Year
- YSXT 2024
- MCRB 2015
- Fundamental
- Price
- YSXT $2.99
- MCRB $13.99
- Analyst Decision
- YSXT
- MCRB Hold
- Analyst Count
- YSXT 0
- MCRB 4
- Target Price
- YSXT N/A
- MCRB $73.67
- AVG Volume (30 Days)
- YSXT 274.1K
- MCRB 148.0K
- Earning Date
- YSXT 08-15-2025
- MCRB 08-06-2025
- Dividend Yield
- YSXT N/A
- MCRB N/A
- EPS Growth
- YSXT N/A
- MCRB N/A
- EPS
- YSXT 0.18
- MCRB 8.98
- Revenue
- YSXT $71,452,736.00
- MCRB N/A
- Revenue This Year
- YSXT N/A
- MCRB N/A
- Revenue Next Year
- YSXT N/A
- MCRB N/A
- P/E Ratio
- YSXT $16.71
- MCRB $1.53
- Revenue Growth
- YSXT 22.04
- MCRB N/A
- 52 Week Low
- YSXT $2.06
- MCRB $6.53
- 52 Week High
- YSXT $9.96
- MCRB $27.40
- Technical
- Relative Strength Index (RSI)
- YSXT N/A
- MCRB 58.12
- Support Level
- YSXT N/A
- MCRB $12.15
- Resistance Level
- YSXT N/A
- MCRB $15.40
- Average True Range (ATR)
- YSXT 0.00
- MCRB 1.36
- MACD
- YSXT 0.00
- MCRB -0.12
- Stochastic Oscillator
- YSXT 0.00
- MCRB 65.29
About YSXT YSX Tech. Co. Ltd Class A Ordinary Shares
YSX Tech Co Ltd provide business solutions to enterprise customers, mainly insurance companies and brokerages, in China. The company has three operating segments: Auto Insurance Aftermarket Value-added Services, Other Scenario-based Customized Services and Software Development and Information Technology Services. Key revenue is generated from Auto Insurance Aftermarket Value-added Services segment which include four types value added services: vehicle safety inspection and check services, vehicle driving risk screening services, designated driver and rescue services and vehicle maintenance and other value-added services.
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a microbiome therapeutics platform company operating in the United States. The company is engaged in developing biological drugs which are referred as ecobiotic microbiome therapeutics. The drugs discovered by the company are designed to restore health by repairing the function of a dysbiotic microbiome. The company focuses on implementing its microbiome therapeutics platform to develop ecobiotic microbiome therapeutics that treat dysbiosis in the colonic microbiome. SER-109, the company's product, is designed to prevent further recurrences of Clostridium difficile infection (CDI), a debilitating infection of the colon. In addition, the company is involved in developing SER-262, SER-287, and SER-401.